Answers are grounded in this paper and cite their sources.
• Organ transplantation is always followed by an early immunologic complication named ‘acute rejection’, and in some cases a delayed pathology, allograft vasculopathy, which was named ‘chronic vascular rejection’. • Due to the introduction of new antirejection drugs, allograft loss due to acute rejection has been significantly reduced, but these drugs have no or little effect on chronic vascular rejection. • While immunologic mechanisms of acute rejection are now well understood, it is not the case for allograft vasculopathy, and its designation as ‘chronic rejection’ has given the wrong impression that the cause of the disease has been identified. • This phenomenon falls under the rubric of linguistic relativity, and the words chosen to name the disease have likely restricted our cognitive ability to solve the problem. While allograft loss due to acute rejection has been dramatically reduced due to the introduction of immunophilins, this therapy has little effect on allografts lost due to chronic vascular rejection. This situation may be due to a misnomer of the pathology. Specifically, its designation as ‘chronic rejection’ has given the wrong impression that the cause of the disease has been identified. Analyzing this phenomenon under the rubric of linguistic relativity suggests that the words chosen to name the disease may have restricted our cognitive ability to solve the problem. Thus, we have to step out of the ‘alloimmunity/rejection box’. Let’s pause between our words, Speak and fall silent again, So that the meaning of the word just spoken, Sounds a clearer echo in our heads. Let’s pause between our words. Andrey Makarevich.
No takes yet. Share an insight, caveat, or question.
Michael Subotin (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: